Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034276590> ?p ?o ?g. }
- W2034276590 endingPage "4693" @default.
- W2034276590 startingPage "4684" @default.
- W2034276590 abstract "Article3 September 2001free access Ski7p G protein interacts with the exosome and the Ski complex for 3′-to-5′ mRNA decay in yeast Yasuhiro Araki Yasuhiro Araki Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Shinya Takahashi Shinya Takahashi Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Tetsuo Kobayashi Tetsuo Kobayashi Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Hiroaki Kajiho Hiroaki Kajiho Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Shin-ichi Hoshino Corresponding Author Shin-ichi Hoshino Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Toshiaki Katada Corresponding Author Toshiaki Katada Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Yasuhiro Araki Yasuhiro Araki Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Shinya Takahashi Shinya Takahashi Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Tetsuo Kobayashi Tetsuo Kobayashi Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Hiroaki Kajiho Hiroaki Kajiho Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Shin-ichi Hoshino Corresponding Author Shin-ichi Hoshino Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Toshiaki Katada Corresponding Author Toshiaki Katada Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan Search for more papers by this author Author Information Yasuhiro Araki1, Shinya Takahashi1, Tetsuo Kobayashi1, Hiroaki Kajiho1, Shin-ichi Hoshino 1 and Toshiaki Katada 1 1Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 113-0033 Japan *Corresponding authors. E-mail: [email protected] or E-mail: [email protected] The EMBO Journal (2001)20:4684-4693https://doi.org/10.1093/emboj/20.17.4684 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Two cytoplasmic mRNA-decay pathways have been characterized in yeast, and both are initiated by shortening of the 3′-poly(A) tail. In the major 5′-to-3′ decay pathway, the deadenylation triggers removal of the 5′-cap, exposing the transcript body for 5′-to-3′ degradation. An alternative 3′-to-5′ decay pathway also follows the deadenylation and requires two multi-complexes: the exosome containing various 3′-exonucleases and the Ski complex consisting of the RNA helicase Ski2p, Ski3p and Ski8p. In addition, Ski7p, which has an N-terminal domain and a C-terminal elongation factor 1α-like GTP-binding domain, is involved in the 3′-to-5′ decay. However, physical interaction between the exosome and the Ski complex, together with the function of Ski7p, has remained unknown. Here we report that the N domain of Ski7p is required and sufficient for the 3′-to-5′ decay. Furthermore, the exosome and the Ski complex interact with the different regions of Ski7p N domain, and both interactions are required for the 3′-to-5′ decay. Thus, Ski7p G protein appears to function as a signal-coupling factor between the two multi-complexes operating in the 3′-to-5′ mRNA-decay pathway. Introduction In addition to transcriptional regulation, mRNA decay plays an important role in the quality and quantity control of gene expression. mRNA degradation is carried out in the nucleus and the cytoplasm of budding yeast Saccharomyces cerevisiae (Bousquet-Antonelli et al., 2000). Two cytoplasmic mRNA-decay pathways have been characterized in yeast (for reviews see Caponigro and Parker, 1996; Mitchell and Tollervey, 2000a). In both, the initial step is shortening of the 3′-poly(A) tail of mRNAs to A10 or less. This step appears to involve the removal of a poly(A)-binding protein (PABP) from the poly(A) tail, to be degraded by a deadenylating enzyme (Coller et al., 1998). In the major pathway, the poly(A) shortening triggers the removal of the 5′-cap structure by a decapping enzyme, Dcp1p, exposing the transcript body to an exonuclease, Xrn1p, for the rapid 5′-to-3′ digestion (Muhlrad and Parker, 1992; Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1994, 1995; Beelman et al., 1996). An alternative 3′-to-5′ degradation pathway also follows the deadenylation and requires at least two multi-complex machineries: the exosome and a ternary complex consisting of Ski2p, Ski3p and Ski8p (we refer to the complex as the Ski complex) (Muhlrad et al., 1995; Jacobs Anderson and Parker, 1998; Brown et al., 2000). The yeast exosome is a protein complex comprising at least 10 essential components. Among them, Rrp4p, Ski6p (Rrp41p) and Rrp44p (Dis3p) have been demonstrated to have 3′-to-5′ exoribonuclease activity in vitro, and the other members (Rrp40p, Rrp42p, Rrp43p, Rrp45p, Rrp46p and Mtr3p) except Csl4p (Ski4p) have high sequence homology to Escherichia coli 3′-to-5′ exoribonucleases, RNase PH and PNPase (for reviews see van Hoof and Parker, 1999; Mitchell and Tollervey, 2000b). The yeast exosome and its human counterpart, the PM-Scl complex, are present in both the cytoplasm and the nucleus (Mitchell et al., 1997; Allmang et al., 1999a). The cytoplasmic exosome degrades mRNAs, whereas the nuclear exosome processes small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and rRNAs, in addition to the degradation of pre-mRNA and pre-rRNA spacer (Mitchell et al., 1997; Jacobs Anderson and Parker, 1998; Allmang et al., 1999a, 2000; van Hoof et al., 2000a). The nuclear exosome has an additional subunit, Rrp6p, which also possesses 3′-to-5′ exoribonuclease activity (Briggs et al., 1998; Allmang et al., 1999b; Burkard and Butler, 2000). Consistent with its nuclear localization, RRP6 mutant strains do not exhibit defects in cytoplasmic mRNA turnover (van Hoof et al., 2000a). On the other hand, the superkiller (SKI) genes encoded in yeast nuclear genome were initially identified from mutations that cause overexpression of a killer toxin encoded by the endogenous double-stranded RNA (Toh-e et al., 1978). Subsequent studies demonstrated that, in addition to the exosome, the products of SKI2, SKI3 and SKI8 genes are required for the 3′-mRNA degradation (Jacobs Anderson and Parker, 1998). Ski2p, Ski3p and Ski8p are a putative RNA helicase, a tetratricopeptide-repeat protein and a protein containing WD motif, respectively (Rhee et al., 1989; Matsumoto et al., 1993; Widner and Wickner, 1993). The three Ski proteins form a stable complex, and the complex is localized in the cytoplasm (Brown et al., 2000). Mutations in the three genes inhibit 3′-to-5′ mRNA decay, but do not affect the other function of the exosome (Jacobs Anderson and Parker, 1998; van Hoof et al., 2000a). Therefore, the Ski complex appears to be a cofactor for the exosome to degrade yeast mRNAs. However, direct interaction between the exosome and the Ski complex has not been observed (Brown et al., 2000). More recently, another member of the Ski proteins, Ski7p, has been reported to be responsible for the 3′-to-5′ mRNA decay (van Hoof et al., 2000b). The SKI7 gene was initially identified as one of the SKI gene family (Benard et al., 1999). van Hoof et al. (2000b) reported that Ski7p is also required for 3′-to-5′ mRNA degradation and acts in the same pathway as Ski2p, Ski3p and Ski8p, because deletion of the SKI7 gene caused impaired 3′-mRNA decay similar to SKI2, SKI3 or SKI8 deletion. However, formation of the Ski complex, which had been impaired in ski2, ski3 or ski8 mutants, was still intact in the ski7 mutant, suggesting that Ski7p is not a member of the Ski complex and is not required for the formation of the Ski complex (Brown et al., 2000). Thus, the roles of Ski7p and the Ski complex members appear to be different in 3′-mRNA degradation. Ski7p is a GTP-binding protein consisting of two separate domains; one is the C-terminal region homologous to the GTP-binding elongation factor 1α (EF1α), and the other is an extra N-terminal domain that was not present in EF1α. This domain structure is quite similar to that of the GTP-binding eukaryotic releasing factor 3 (eRF3). We previously indicated that eRF3 functions not only in translation termination, but also as an initiator of poly(A) shortening by interacting with PABP (Hoshino et al., 1998, 1999b). The N domain of eRF3 associated with PABP to unmask the poly(A) tail of mRNAs, presumably for their degradation (Hoshino et al., 1999b). In order to understand the molecular details of the 3′-mRNA decay pathway, we investigated the role of Ski7p and its interacting molecules. Here we report that the N domain of Ski7p is required and sufficient, and its EF1α-like C domain is dispensable, for the 3′-to-5′ mRNA degradation. Furthermore, the Ski7p N domain was capable of interacting with the exosome and the Ski complex physically and functionally. Thus, the N domains of this G protein family appear to function in common as regulatory factors in mRNA-decay pathways. Results Ski7p is involved in the cytoplasmic 3′-to-5′ mRNA-decay pathway A recent study has revealed that Ski7p is required for 3′-to-5′ degradation of yeast mRNAs (van Hoof et al., 2000b). We first confirmed the previous findings using an MFA2pG mRNA that contained a poly(G) tract inserted into its 3′-untranslated region. Since the poly(G) tract forms a stable structure that inhibits 5′-exoribonuclease activity (Decker and Parker, 1993), 5′-to-3′ degradation of the mRNA produces an intermediate that stretches from the poly(G) tract to the 3′ end of the mRNA. The resultant intermediate is normally degraded by the 3′-to-5′ mRNA-degradation pathway (Jacobs Anderson and Parker, 1998). Thus, mutants having a defect in 3′-to-5′ decay show a slow digestion of the 3′-end fragment, resulting in the accumulation of its fragments upon northern blot analysis. In accordance with the previous report (van Hoof et al., 2000b), deletion of the SKI7 gene (ski7Δ) caused accumulation of the 3′-end fragments of MFA2pG mRNA (data not shown, but see Figure 2). Figure 1.Intracellular localization of Ski7p in yeast. A yeast strain expressing Myc-tagged SKI7 (MC028, top panels) and the wild type (W303a, bottom panels) were analyzed by confocal microscopy as described in Materials and methods. (A) Nomarski images of the cells. (B) DNA of the cells was stained with PicoGreen. (C) Ski7p-Myc was stained with anti-Myc (primary) and anti-mouse IgG coupled to Alexa-568 (secondary) antibodies. (D) Overlay of the two signals shown in (B) and (C). Download figure Download PowerPoint Figure 2.The N domain of Ski7p is necessary and sufficient for the 3′-to-5′ degradation of mRNA. Yeast strains MC046 (vector), MC047 (Ski7p/N), MC048 (Ski7p/C) and MC049 (Ski7p/Full), carrying the GAL1:MFA2pG reporter, were grown in a galactose-containing medium and harvested at the mid-log phase (OD600 = 0.4–0.5). RNA extracted from the cells was subjected to polyacrylamide gel northern blot analysis as described in Materials and methods. Positions of the full-length and poly(G) (pG) to 3′-end fragments of MFA2pG mRNA are indicated on the left. ORF, open reading frame. Download figure Download PowerPoint If Ski7p is directly involved in the cytoplasmic 3′-mRNA-decay pathway, at least a portion of this protein should be present in the cytoplasm. The chromosomal copy of SKI7 was tagged with nine Myc epitopes (Ski7p-Myc), and the Myc-tagged protein was produced under native transcriptional conditions. Figure 1 shows the cellular localization of Ski7p-Myc observed by indirect immunofluorescence, together with nuclear DNA stained with PicoGreen. Ski7p-Myc localized primarily in the cytoplasm and did not overlap with the nuclear signals. These observations suggested that Ski7p is directly involved in the 3′-to-5′ mRNA-decay pathway in yeast cytoplasm. Ski7p N domain is required and sufficient for the 3′-to-5′ mRNA degradation Ski7p consists of two separated domains, the extra N-terminal domain (amino acid sequence 1–264) and the C-terminal EF1α-like domain (sequence 265–747). To identify which domain is responsible for the 3′-mRNA decay, each of the two domains was expressed in the ski7Δ strain. As shown in Figure 2, the N domain of Ski7p (Ski7p/N), together with the full-length form (Ski7p/Full), rescued the ski7Δ phenotype, which was characterized by the accumulation of 3′-end fragments of MFA2pG mRNA. However, such recovery was not observed with the EF1α-like C domain (Ski7p/C). This indicated that Ski7p/N is required and sufficient, and Ski7p/C is dispensable, for the 3′-mRNA decay. Ski7p interacts physically with both the exosome and the Ski complex It has been reported that 3′-to-5′ mRNA degradation in yeast requires at least two multi-complexes: the exosome and the Ski complex consisting of Ski2p, Ski3p and Ski8p (Jacobs Anderson and Parker, 1998). Therefore, we investigated whether Ski7p was capable of interacting with these components (Figure 3). The chromosomal copies of SKI2 and SKI8 were tagged with Myc and hemagglutinin (HA) epitopes, respectively, and vectors expressing Ski7p-deletion variants under the control of the GAL1 promoter were introduced into the same yeast strain with a Flag epitope. Extracts were prepared from these strains and subjected to immunoprecipitation assay with an anti-Flag antibody. As shown in Figure 3B and D, both members of the Ski complex, Ski2p-Myc and Ski8p-HA, were co-precipitated with Ski7p/N and Ski7p/Full, but not with Ski7p/C. We also tagged the chromosomal copies of RRP4 and SKI6, the components of the exosome, with Myc and HA epitopes. As shown in Figure 3G and I, not only Rrp4p-Myc, but also Ski6p-HA, could be detected in the fractions precipitated with Ski7p/N and Ski7p/Full. These experiments were performed with the constructs overexpressing Ski7p variants. However, we found that the expression constructs rescued the phenotype of the SKI7-disruption strain (see Figure 2). Therefore, these interactions could be detected with a normal level of Ski7p. When yeast cell extract was fractionated on a gel-filtration column, Ski7p behaved as a complex (>300 kDa protein) larger than its predicted 85 kDa monomer, and it appeared to associate with the components of the Ski complex and the exosome (data not shown). Thus, the N domain of Ski7p is capable of interacting physically with the components of both the Ski complex and the exosome. Figure 3.The N domain of Ski7p interacts with the components of the Ski complex and the exosome. Cell extracts were obtained from the indicated yeast strains expressing Ski2p-Myc and Ski8p-HA (A–E) or Prp4p-Myc and Ski6p-HA (F–J). The yeast strains also expressed the indicated forms of Flag-tagged Ski7p (A–E, lanes 1–4 for MC146–MC149; F–J, lanes 1–4 for MC151–MC154). The cell extracts were immunoprecipitated (IP) with an anti-Flag antibody. The precipitated proteins (B, D, E, G, I and J), together with the whole-cell extracts (A, C, F and H), were immunoblotted (IB) with anti-Myc (9E10), anti-HA (12CA5), and anti-Flag (M2) antibodies to detect Ski2p (or Rrp4p), Ski8p (or Ski6p) and Ski7p. The asterisks in (E) and (J) indicate Flag-tagged Ski7p mutants expressed in the various strains. The arrowheads indicate the positions of IgG bands. Download figure Download PowerPoint Ski7p interacts with the exosome independently of its interaction with the Ski complex Disruption of SKI8 has been shown to abolish the association between Ski2p and Ski3p (Brown et al., 2000). Therefore, we tested whether the deletion of SKI8 could exert its influence on the Ski7p–Ski2p and/or Ski7p–Rrp4p interaction. As shown in Figure 4B, the association of Ski7p/N (or Ski7p/Full) with Ski2p observed in Ski8p-expressing strains was completely abolished in SKI8-disruption strains (ski8Δ). However, the interaction between Ski7p/N (or Ski7p/Full) and Rrp4p was still present in the ski8Δ strains (Figure 4E). These results indicated that an intact form of the Ski complex is required for the association between Ski7p and the Ski complex, and that the interaction between Ski7p and the exosome is unaffected by the presence or absence of the Ski complex. Figure 4.Interaction of the N domain of Ski7p with Rrp4p is maintained in the Ski complex-disrupted yeast strains. Cell extracts were prepared from wild-type SKI8 or ski8Δ strains carrying Ski2p-Myc (A–C, lanes 1–6 for MC052, MC053, MC055, MC130, MC131 and MC133) or Rrp4p-Myc (D–F, lanes 1–6 for MC126, MC127, MC129, MC134, MC135 and MC137). The yeast strains also expressed the indicated forms of Flag-tagged Ski7p. The cell extracts were immunoprecipitated (IP) with the anti-Flag antibody. The precipitated proteins (B, C, E and F), together with the whole-cell extracts (A and D), were immunoblotted (IB) with anti-Myc (9E10) and anti-Flag (M2) antibodies to detect Ski2p (or Rrp4p) and Ski7p, respectively. The asterisks in (C) and (F) indicate Flag-tagged Ski7p mutants expressed in the various strains. The arrowheads indicate the positions of IgG bands. Download figure Download PowerPoint The Ski complex and the exosome interact with the different regions of the Ski7p N domain Since Ski7p appeared to interact with the Ski complex and the exosome independently through the N domain, we mapped binding regions for the two multi-complexes on the N domain. Yeast strains expressing five different Flag-tagged variants of Ski7p/N were prepared (see Figure 8), and the association with the Ski complex and the exosome was investigated by immunoprecipitation assay with the anti-Flag antibody. As shown in Figure 5B and D, the Ski complex-binding region, which had been measured by Ski2p-Myc and Ski8p-HA binding, was located in the amino acid sequence 1–96 of Ski7p/N. On the other hand, either of the two sequences, 80–184 or 168–264 of Ski7p, was sufficient for the association with the exosome measured by Rrp4p-Myc and Ski6p-HA binding (Figure 5G and I). It is unlikely that the exosome-binding site was present in only the overlapped region 168–184 between the above independent two sequences, since the more narrow sequences 80–176 and 177–264 were both capable of binding to the exosome (data not shown). Taken together, these results indicated that different regions on Ski7p/N are involved in the interaction with the exosome and the Ski complex. Figure 5.The Ski complex and the exosome interact with the different regions of the Ski7p N domain. Cell extracts were obtained from the indicated yeast strains expressing Skip2-Myc and Ski6p-HA (A–E) or Prp4p-Myc and Ski2p-HA (F–J). The yeast strains (MC146, MC147, MC151, MC152, MC155–164) also expressed the various deletion mutants of Ski7p N domain with a Flag tag (lanes 1–7). The cell extracts were immunoprecipitated (IP) with the anti-Flag antibody. The precipitated proteins (B, D, E, G, I and J), together with the whole-cell extracts (A, C, F and H), were immuno blotted (IB) with anti-Myc (9E10), anti-HA (12CA5) and anti-Flag (M2) antibodies to detect Ski2p (or Rrp4p), Ski8p (or Ski6p) and Ski7p. The asterisks in (E) and (J) indicate Flag-tagged Ski7p mutants expressed in the various strains. The arrowheads indicate the positions of IgG bands. Download figure Download PowerPoint Interaction of Ski7p/N with both the exosome and the Ski complex is required for 3′-to-5′ mRNA decay We investigated further which regions on Ski7p/N were responsible for the 3′-to-5′ mRNA decay. The five Ski7p/N-deletion variants used in Figure 5 were expressed in the ski7Δ strain, and their effects on the MFA2pG mRNA decay were monitored by northern blot analysis. As shown in Figure 6, all five deletion variants failed to rescue the ski7Δ phenotype; the accumulation of 3′-end fragments of MFA2pG mRNA was only abolished by the presence of the whole Ski7p/N sequence (lane 2). These results are consistent with the theory that Ski7p functions in 3′-to-5′ mRNA decay through its interaction with both the Ski complex and the exosome. Figure 6.Both the Ski complex- and the exosome-binding regions of Ski7p N domain are required for the 3′-to-5′ degradation of mRNA. The ski7Δ strain was transformed with plasmids carrying the indicated deletion mutants of Ski7p N domain (lanes 1–7 for MC046, MC047 and MC138–MC142). The transfected cells were grown in the galactose-containing medium and harvested at mid-log phase. RNA extracted from the cells was subjected to polyacrylamide gel northern blot analysis as described in Figure 2. Positions of the full-length and poly(G) to 3′-end fragments of MFA2pG mRNA are indicated on the left. Download figure Download PowerPoint This theory predicted that interfering with either the interaction of Ski7p with the Ski complex or the exosome would stabilize 3′-to-5′ mRNA degradation. To test this prediction, we overexpressed the deletion variants of Ski7p/N in a wild-type strain containing MFA2pG mRNA. As shown in Figure 7, expression of the two mutants induced significant inhibition of 3′-to-5′ mRNA decay. One mutant was the sequence 1–96, identified as the Ski complex-binding region (see Figure 5B and D), and the other mutant was the sequence 80–264, which includes both exosome-binding regions (see Figure 5G and I). In addition, the sequence 1–184, which contains the Ski complex-binding region and one of the two exosome-binding regions, also inhibited the 3′-mRNA decay, but to a lesser extent. The lesser effect of the sequence 1–184 might be due to its low-level expression under the present experimental conditions (data not shown, but see Figure 5E and J). We thus concluded that the interaction between Ski7p/N and the two multi-complexes, the Ski complex and the exosome, is required for 3′-to-5′ mRNA degradation. Figure 7.Inhibition of 3′-to-5′ mRNA degradation by overexpressing either the Ski complex- or exosome-binding region of Ski7p N domain. The yeast strain MC035 (SKI7; wild type) was transformed with plasmids carrying the indicated deletion mutants of Ski7p N domain (lanes 1–8 for MC046, MC043, MC118–MC122 and MC042). The transfected cells were grown in the galactose-containing medium and harvested at mid-log phase. RNA extracted from the cells was subjected to polyacrylamide gel northern blot analysis as described in Figure 2. Positions of the full-length and poly(G) to 3′-end fragments of MFA2pG mRNA are indicated on the left. Download figure Download PowerPoint Figure 8.The N domain of Ski7p interacting with the Ski complex and the exosome. (A) Deletion mutants of Ski7p used in this study and the summary of the present results obtained in Figures 5, 6 and 7. (B) A proposed model for the Ski complex- and the exosome-interacting sites of the Ski7p N domain. Download figure Download PowerPoint Discussion A recent study has revealed that Ski7p is a new member involved in the 3′-to-5′ mRNA-decay pathway in yeast cytoplasm, and that its role in mRNA decay may be different from those of the other members of the SKI gene family (van Hoof et al., 2000b). This idea was confirmed and extended further by our present findings. First, Ski7p did indeed exhibit cytoplasmic distribution in yeast (Figure 1). Secondly, the N-terminal domain of Ski7p is required and sufficient for 3′-to-5′ mRNA degradation. Its EF1α-like C domain was dispensable for the function of Ski7p (Figure 2). Thirdly, the exosome and the Ski complex, which are known to be multi-complex machineries involved in 3′-mRNA decay, interacted physically with the different regions of Ski7p/N (Figures 3, 4 and 5). Fourthly, interaction of Ski7p/N with the two complexes appeared to be required for 3′-to-5′ mRNA decay (Figures 6 and 7). We thus concluded that the N domain of Ski7p mediates 3′-to-5′ mRNA degradation through its interaction with the exosome and the Ski complex (Figure 8). Possible roles of Ski7p in the cytoplasmic mRNA decay of yeast In the present study, we indicated that both the Ski complex and the exosome are capable of interacting with Ski7p/N, although direct binding of their constituent components to Ski7p/N has not been determined yet. The interacting sites of the two complexes were mapped on the different regions of Ski7p/N. Moreover, Ski7p/N was essential and sufficient for cytoplasmic 3′-to-5′ mRNA decay. These findings gave rise to an important question of how Ski7p/N regulates mRNA decay. There may be at least two independent mechanisms in Ski7p-induced mRNA degradation. One is that Ski7p/N binds to the Ski complex and the exosome in order to stimulate their intrinsic enzyme activities, such as RNA helicase of Ski2p and exoribonucleases in the exosome. Although the effects of Ski7p/N on the enzymatic activities have not been investigated in the present study, the above idea would be consistent with the following observations. Two RNA helicases, RhlB and eIF4A, associated with RNase E and eIF4B, respectively, and these interactions appeared to result in stimulation of their ATPase activities (Rozen et al., 1990; Vanzo et al., 1998). Alternatively, Ski7p/N may function as a coupling factor between the Ski complex and the exosome for mRNA decay. In E.coli, the degradosome, a complex of RNase E, a polynucleotide phosphorylase and the RNA helicase RhlB, is required for 3′-to-5′ degradation of mRNA (Carpousis et al., 1994; Py et al., 1996). The C-terminal half of RNase E constitutes binding sites for each of the other two degradosomal components (Kaberdin et al., 1998; Vanzo et al., 1998). In vitro analysis of the E.coli degradosome indicates that RhlB is required for degradation of structured RNA substrates in a manner dependent on ATP (Py et al., 1996; Coburn et al., 1999). Similarly, Suv3p, a yeast mitochondrial RNA helicase, is a component of the mtEXO complex, which also contains the 3′-exoribonuclease Dss1p (Msu1p) and is required for intron degradation (Margossian et al., 1996). These findings may suggest that the RNA helicase (Ski2p of the Ski complex) and the exoribonucleases in the exosome might form a multi-complex via Ski7p/N for 3′-mRNA degradation. However, the Ski7p–Ski complex and Ski7p–exosome complex appeared to be present separately in yeast cytoplasm, since Ski7p was, but Ski2p (the component of the Ski complex) was not, co-immunoprecipitated with Rrp4p of the exosome (data not shown). These observations imply that a ternary complex consisting of Ski7p, the Ski complex and the exosome may not exist at the same time. This is consistent with a previous report showing that there is no direct interaction between the Ski complex and the exosome (Brown et al., 2000). Thus, it is very likely that the two complexes associating with Ski7p are formed separately, probably in sequential steps of the mRNA-decay pathway. Although further experiments are required to elucidate the molecular mechanism, our present report is the first indication that Ski7p may function as a signal-coupling factor between the RNA helicase and the exoribonucleases. Comparison between cytoplasmic and nuclear mRNA degradation in yeast The degradation of yeast mRNAs takes place in the nucleus as well as in the cytoplasm (Bousquet-Antonelli et al., 2000). There are many similarities between the nuclear pre-mRNA-degradation and cytoplasmic mRNA-decay pathways. Both pathways involve 3′-to-5′ degradation by their exosomes, while 5′-to-3′ degradation is carried out by two homologous exoribonucleases: Rat1p in the nucleus and Xrn1p in the cytoplasm (Hsu and Stevens, 1993; Muhlrad et al., 1994, 1995; Johnson, 1997; Jacobs Anderson and Parker, 1998; Bousquet-Antonelli et al., 2000). Therefore, we predict that the two 3′-to-5′ decay pathways may be carried out in a similar fashion. Both processing and degradative activities in their exosomes have been shown to require substrate-specific cofactor(s) (van Hoof and Parker, 1999). The Ski complex and Ski7p are thus cofactors for the cytoplasmic mRNA decay induced by the exosome, although factors for nuclear pre-mRNA degradation have not yet been determined. It is unlikely that the Ski complex and Ski7p also function in pre-mRNA degradation because of their cytoplasmic localization. An interesting model proposed previously was that the role of Mtr4p (Dob1p) could be analogous to that of Ski2p (de la Cruz et al., 1998). This prediction was based on the following observations. First, Mtr4p, a putative ATP-dependent RNA helicase, is highly homologous to Ski2p. Secondly, this molecule functions as an accessory factor for the nuclear form of the exosome, which is involved in 3′-to-5′ exonucleolytic processi" @default.
- W2034276590 created "2016-06-24" @default.
- W2034276590 creator A5008073452 @default.
- W2034276590 date "2001-09-03" @default.
- W2034276590 modified "2023-10-18" @default.
- W2034276590 title "Ski7p G protein interacts with the exosome and the Ski complex for 3'-to-5' mRNA decay in yeast" @default.
- W2034276590 cites W137442702 @default.
- W2034276590 cites W1509729044 @default.
- W2034276590 cites W1524542249 @default.
- W2034276590 cites W164713944 @default.
- W2034276590 cites W1803296362 @default.
- W2034276590 cites W1967520902 @default.
- W2034276590 cites W1973782344 @default.
- W2034276590 cites W1976799609 @default.
- W2034276590 cites W1978809302 @default.
- W2034276590 cites W1989332737 @default.
- W2034276590 cites W2005982219 @default.
- W2034276590 cites W2023695925 @default.
- W2034276590 cites W2028513775 @default.
- W2034276590 cites W2028662837 @default.
- W2034276590 cites W2035792284 @default.
- W2034276590 cites W2037239669 @default.
- W2034276590 cites W2040010148 @default.
- W2034276590 cites W2044386270 @default.
- W2034276590 cites W2049830784 @default.
- W2034276590 cites W2050269111 @default.
- W2034276590 cites W2066886643 @default.
- W2034276590 cites W2073477066 @default.
- W2034276590 cites W2075736819 @default.
- W2034276590 cites W2080408951 @default.
- W2034276590 cites W2082658854 @default.
- W2034276590 cites W2085456081 @default.
- W2034276590 cites W2090850551 @default.
- W2034276590 cites W2104496647 @default.
- W2034276590 cites W2105377891 @default.
- W2034276590 cites W2110544609 @default.
- W2034276590 cites W2115761677 @default.
- W2034276590 cites W2118880717 @default.
- W2034276590 cites W2125150600 @default.
- W2034276590 cites W2125762953 @default.
- W2034276590 cites W2129232563 @default.
- W2034276590 cites W2130942741 @default.
- W2034276590 cites W2132398035 @default.
- W2034276590 cites W2134910640 @default.
- W2034276590 cites W2142985191 @default.
- W2034276590 cites W2143828806 @default.
- W2034276590 cites W2146393576 @default.
- W2034276590 cites W2152231771 @default.
- W2034276590 cites W2152656750 @default.
- W2034276590 cites W2156758502 @default.
- W2034276590 cites W2157099873 @default.
- W2034276590 cites W2160773412 @default.
- W2034276590 cites W2161714250 @default.
- W2034276590 cites W2164006415 @default.
- W2034276590 cites W2168149109 @default.
- W2034276590 cites W2169333620 @default.
- W2034276590 doi "https://doi.org/10.1093/emboj/20.17.4684" @default.
- W2034276590 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/125587" @default.
- W2034276590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11532933" @default.
- W2034276590 hasPublicationYear "2001" @default.
- W2034276590 type Work @default.
- W2034276590 sameAs 2034276590 @default.
- W2034276590 citedByCount "201" @default.
- W2034276590 countsByYear W20342765902012 @default.
- W2034276590 countsByYear W20342765902013 @default.
- W2034276590 countsByYear W20342765902014 @default.
- W2034276590 countsByYear W20342765902015 @default.
- W2034276590 countsByYear W20342765902016 @default.
- W2034276590 countsByYear W20342765902017 @default.
- W2034276590 countsByYear W20342765902018 @default.
- W2034276590 countsByYear W20342765902019 @default.
- W2034276590 countsByYear W20342765902020 @default.
- W2034276590 countsByYear W20342765902021 @default.
- W2034276590 countsByYear W20342765902022 @default.
- W2034276590 countsByYear W20342765902023 @default.
- W2034276590 crossrefType "journal-article" @default.
- W2034276590 hasAuthorship W2034276590A5008073452 @default.
- W2034276590 hasBestOaLocation W20342765901 @default.
- W2034276590 hasConcept C104317684 @default.
- W2034276590 hasConcept C105580179 @default.
- W2034276590 hasConcept C145059251 @default.
- W2034276590 hasConcept C153911025 @default.
- W2034276590 hasConcept C20518536 @default.
- W2034276590 hasConcept C2777576037 @default.
- W2034276590 hasConcept C2779222958 @default.
- W2034276590 hasConcept C2781261824 @default.
- W2034276590 hasConcept C2991743866 @default.
- W2034276590 hasConcept C54355233 @default.
- W2034276590 hasConcept C75449159 @default.
- W2034276590 hasConcept C86803240 @default.
- W2034276590 hasConcept C95444343 @default.
- W2034276590 hasConceptScore W2034276590C104317684 @default.
- W2034276590 hasConceptScore W2034276590C105580179 @default.
- W2034276590 hasConceptScore W2034276590C145059251 @default.
- W2034276590 hasConceptScore W2034276590C153911025 @default.
- W2034276590 hasConceptScore W2034276590C20518536 @default.
- W2034276590 hasConceptScore W2034276590C2777576037 @default.
- W2034276590 hasConceptScore W2034276590C2779222958 @default.